On August 11, 2023, Elevar Therapeutics, Inc. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
48,500 KRW | +3.19% | -48.73% | -4.34% |
1st Jan change | Capi. | |
---|---|---|
-4.34% | 4.65B | |
-6.46% | 179B | |
+3.39% | 113B | |
-3.68% | 67.88B | |
+5.44% | 52.03B | |
+5.70% | 43.3B | |
+4.03% | 41.79B | |
+25.42% | 32.49B | |
+14.00% | 25.65B | |
-4.29% | 24.55B |
- Stock Market
- Equities
- A028300 Stock
- News HLB Co., Ltd.
- Elevar Therapeutics, Inc. announced that it has received KRW 58.174676146 billion in funding from HLB Co., Ltd.